These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
756 related items for PubMed ID: 26649802
1. Comparison of the ability of the PDD-ICG clearance test, CTP, MELD, and MELD-Na to predict short-term and medium-term mortality in patients with decompensated hepatitis B cirrhosis. Cheng XP, Zhao J, Chen Y, Meng FK, Xu B, Yu HW, Meng QH, Liu YM, Zhang SB, Meng S, Zhang JY, Zhang JY, Duan ZP, Zheng SJ. Eur J Gastroenterol Hepatol; 2016 Apr; 28(4):444-8. PubMed ID: 26649802 [Abstract] [Full Text] [Related]
2. Indocyanine green clearance test and model for end-stage liver disease score of patients with liver cirrhosis. Sheng QS, Lang R, He Q, Yang YJ, Zhao DF, Chen DZ. Hepatobiliary Pancreat Dis Int; 2009 Feb; 8(1):46-9. PubMed ID: 19208514 [Abstract] [Full Text] [Related]
3. Evaluation of indocyanine green clearance and model for end-stage liver disease for estimation of short-term prognosis in decompensated cirrhosis. Stauber RE, Wagner D, Stadlbauer V, Palma S, Gurakuqi G, Kniepeiss D, Iberer F, Smolle KH, Haas J, Trauner M. Liver Int; 2009 Nov; 29(10):1516-20. PubMed ID: 19732329 [Abstract] [Full Text] [Related]
4. Prognostic Value of Metabolic Liver Function Tests: a Study on 711 Cirrhotic Patients. Lebossé F, Guillaud O, Forestier J, Ecochard M, Boillot O, Roman S, Mion F, Dumortier J. J Gastrointestin Liver Dis; 2016 Sep; 25(3):337-43. PubMed ID: 27689198 [Abstract] [Full Text] [Related]
6. [Assessment of the predictive value of the model for end-stage liver disease scoring system combined with the indocyanine green clearance test for short-term prognosis of acute-on-chronic hepatitis B liver failure]. Tang K, Shan J, Tian F, Cao W. Zhonghua Gan Zang Bing Za Zhi; 2014 Mar; 22(3):190-4. PubMed ID: 24824120 [Abstract] [Full Text] [Related]
8. Incorporating indocyanin green clearance into the Model for End Stage Liver Disease (MELD-ICG) improves prognostic accuracy in intermediate to advanced cirrhosis. Zipprich A, Kuss O, Rogowski S, Kleber G, Lotterer E, Seufferlein T, Fleig WE, Dollinger MM. Gut; 2010 Jul; 59(7):963-8. PubMed ID: 20581243 [Abstract] [Full Text] [Related]
12. Indocyanine green clearance test (using spectrophotometry) and its correlation with model for end stage liver disease (MELD) score in Indian patients with cirrhosis of liver. Gupta S, Chawla Y, Kaur J, Saxena R, Duseja A, Dhiman RK, Choudhary NS. Trop Gastroenterol; 2012 Jul; 33(2):129-34. PubMed ID: 23025060 [Abstract] [Full Text] [Related]
13. Impact of pretransplant MELD score on posttransplant outcome in orthotopic liver transplantation for patients with acute-on-chronic hepatitis B liver failure. Wang ZX, Yan LN, Wang WT, Xu MQ, Yang JY. Transplant Proc; 2007 Jun; 39(5):1501-4. PubMed ID: 17580172 [Abstract] [Full Text] [Related]
14. [Prognostic value of the model for end-stage liver disease combined with serum sodium levels in patients with decompensated cirrhosis]. Li JY, Deng Q, Wang Y, Xu MY, Lu LG. Zhonghua Gan Zang Bing Za Zhi; 2012 Dec; 20(12):896-901. PubMed ID: 23522249 [Abstract] [Full Text] [Related]
15. [Comparative study of the MELD-Na and Child-Turcotte-Pugh scores as short-term prognostic indicators of acute-on-chronic hepatitis B liver failure]. Chen K, Cao X, Zheng Y, Xu M, Peng J. Zhonghua Gan Zang Bing Za Zhi; 2014 Nov; 22(11):801-5. PubMed ID: 25531374 [Abstract] [Full Text] [Related]
18. Identification of patients with decompensated cirrhosis at high risk for death: improving the prediction by hepatic venous pressure gradient? Park SH, Park HY, Kang JW, Park JS, Shin KJ, Kim CH, Suk KT, Baik GH, Kim JB, Kim DJ, Lee HY. Hepatogastroenterology; 2012 Nov; 59(120):2548-51. PubMed ID: 23178621 [Abstract] [Full Text] [Related]